Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Host-guest supramolecular hydrogel based on nanoparticles: co-delivery of DOX and siBcl-2 for synergistic cancer therapy.

Peng D, Gao H, Huang P, Shi X, Zhou J, Zhang J, Dong A, Tang H, Wang W, Deng L.

J Biomater Sci Polym Ed. 2019 Jul;30(10):877-893. doi: 10.1080/09205063.2019.1612602. Epub 2019 May 11.

PMID:
31025910
2.

Supramolecular hydrogel based on high-solid-content mPECT nanoparticles and cyclodextrins for local and sustained drug delivery.

Yin L, Xu S, Feng Z, Deng H, Zhang J, Gao H, Deng L, Tang H, Dong A.

Biomater Sci. 2017 Mar 28;5(4):698-706. doi: 10.1039/c6bm00889e.

PMID:
28184404
3.

Supramolecular Hydrogel from Nanoparticles and Cyclodextrins for Local and Sustained Nanoparticle Delivery.

Xu S, Yin L, Xiang Y, Deng H, Deng L, Fan H, Tang H, Zhang J, Dong A.

Macromol Biosci. 2016 Aug;16(8):1188-99. doi: 10.1002/mabi.201600076. Epub 2016 Apr 23.

PMID:
27105589
4.

D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.

Tan X, Fang Y, Ren Y, Li Y, Wu P, Yang X, Liu W.

Int J Nanomedicine. 2019 Feb 18;14:1255-1268. doi: 10.2147/IJN.S191858. eCollection 2019.

5.

Development of curcumin-loaded methoxy poly(ethylene glycol)-block- poly(caprolactone)-block-poly(1, 4, 8-Trioxa [4.6] spiro-9-undecanone) nanoparticles and studies on their in vitro anti-tumor activities.

Shi Y, Ma W, Gao M, Yang Y.

Colloids Surf B Biointerfaces. 2019 Sep 25;184:110525. doi: 10.1016/j.colsurfb.2019.110525. [Epub ahead of print]

PMID:
31585307
6.

Preparation and investigation of high solid content PTX-loaded nanoparticles dispersion via nanoprecipitation method.

Xiang Y, Xiao M, Han S, Xu S, Cao Y, Lv Z, Liu J, Liu J, Deng L, Dong A.

J Biomater Sci Polym Ed. 2014;25(11):1144-58. doi: 10.1080/09205063.2014.923365. Epub 2014 Jun 4.

PMID:
24894948
7.

Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.

Chang L, Deng L, Wang W, Lv Z, Hu F, Dong A, Zhang J.

Biomacromolecules. 2012 Oct 8;13(10):3301-10. doi: 10.1021/bm301086c. Epub 2012 Sep 14.

PMID:
22931197
8.

Bridging the Gap between Macroscale Drug Delivery Systems and Nanomedicines: A Nanoparticle-Assembled Thermosensitive Hydrogel for Peritumoral Chemotherapy.

Huang P, Song H, Zhang Y, Liu J, Zhang J, Wang W, Liu J, Li C, Kong D.

ACS Appl Mater Interfaces. 2016 Nov 2;8(43):29323-29333. Epub 2016 Oct 19.

PMID:
27731617
9.

Injectable supramolecular hydrogel formed from α-cyclodextrin and PEGylated arginine-functionalized poly(l-lysine) dendron for sustained MMP-9 shRNA plasmid delivery.

Lin Q, Yang Y, Hu Q, Guo Z, Liu T, Xu J, Wu J, Kirk TB, Ma D, Xue W.

Acta Biomater. 2017 Feb;49:456-471. doi: 10.1016/j.actbio.2016.11.062. Epub 2016 Nov 30.

PMID:
27915016
10.

Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.

Tao X, Gou J, Zhang Q, Tan X, Ren T, Yao Q, Tian B, Kou L, Zhang L, Tang X.

Biomater Sci. 2018 Jun 25;6(7):1869-1881. doi: 10.1039/c8bm00271a.

PMID:
29808221
11.

Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.

Zhang D, Kong YY, Sun JH, Huo SJ, Zhou M, Gui YL, Mu X, Chen H, Yu SQ, Xu Q.

Int J Nanomedicine. 2017 Mar 16;12:2081-2108. doi: 10.2147/IJN.S128790. eCollection 2017.

12.

A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(l-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo.

Zhang Y, Xiao C, Ding J, Li M, Chen X, Tang Z, Zhuang X, Chen X.

Acta Biomater. 2016 Aug;40:243-253. doi: 10.1016/j.actbio.2016.04.007. Epub 2016 Apr 7.

PMID:
27063495
13.

Preparation of Graphene Oxide-Based Supramolecular Hybrid Nanohydrogel Through Host-Guest Interaction and Its Application in Drug Delivery.

Zhang Q, Deng H, Li H, Song K, Zeng C, Rong L.

J Biomed Nanotechnol. 2018 Dec 1;14(12):2056-2065. doi: 10.1166/jbn.2018.2648.

PMID:
30305213
14.

Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance.

Yu M, Han S, Kou Z, Dai J, Liu J, Wei C, Li Y, Jiang L, Sun Y.

Artif Cells Nanomed Biotechnol. 2018 Mar;46(2):323-332. doi: 10.1080/21691401.2017.1307215. Epub 2017 Apr 10.

PMID:
28393563
15.

Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.

Yan J, Ye Z, Chen M, Liu Z, Xiao Y, Zhang Y, Zhou Y, Tan W, Lang M.

Biomacromolecules. 2011 Jul 11;12(7):2562-72. doi: 10.1021/bm200375x. Epub 2011 Jun 6.

PMID:
21598958
16.

pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.

Zhang J, Li J, Shi Z, Yang Y, Xie X, Lee SM, Wang Y, Leong KW, Chen M.

Acta Biomater. 2017 Aug;58:349-364. doi: 10.1016/j.actbio.2017.04.029. Epub 2017 Apr 26.

PMID:
28455219
17.
18.

pH-Responsive Poly(ethylene glycol)/Poly(L-lactide) Supramolecular Micelles Based on Host-Guest Interaction.

Zhang Z, Lv Q, Gao X, Chen L, Cao Y, Yu S, He C, Chen X.

ACS Appl Mater Interfaces. 2015 Apr 29;7(16):8404-11. doi: 10.1021/acsami.5b01213. Epub 2015 Apr 17.

PMID:
25856564
19.

Injectable Supramolecular Hydrogels as Delivery Agents of Bcl-2 Conversion Gene for the Effective Shrinkage of Therapeutic Resistance Tumors.

Liu X, Chen X, Chua MX, Li Z, Loh XJ, Wu YL.

Adv Healthc Mater. 2017 Jun;6(11). doi: 10.1002/adhm.201700159. Epub 2017 May 8.

PMID:
28481473
20.

Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.

Cabeza L, Ortiz R, Prados J, Delgado ÁV, Martín-Villena MJ, Clares B, Perazzoli G, Entrena JM, Melguizo C, Arias JL.

Eur J Pharm Sci. 2017 May 1;102:24-34. doi: 10.1016/j.ejps.2017.02.026. Epub 2017 Feb 17.

PMID:
28219748

Supplemental Content

Support Center